Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

TriStem

The TriStem Group has been set up by Mr.Ghazi Dhoot and Dr. Ilham Saleh Abuljadayel to further research and develop its retrodifferentiation technology which is used to create stem cells from mature adult cells. The retrodifferentiation technology is based on the results of 12 years of research and currently TriStem is the only company that owns, and is in the process of commercialising, this technology. The main advantage of TriStem's new process over existing methods of harvesting stem cells is that it provides large quantities of stem cells which are by definition DNA matched and, therefore, bypasses the political and ethical issues concerned with therapeutic cloning.


Contact Details:
571, Finchley Road,Unit 320
London
London
NW3 7BN
United Kingdom
Tel:
Fax:
Email:info@tristemcorp.com
WWW:

www.tristemcorp.com/




Loading...

Recent Publications by TriStem:

Harnessing pluripotency from differentiated cells: a regenerative source for tissue-specific stem cell therapies.
Processes involving conversion of mature adult cells into undifferentiated...
27th February, 2008
TriStem UK Limited, 571 Finchley Road, Unit 320, London NW3 7BN, England. Curr Stem Cell Res Ther. 2006 Sep;1(3):325-31.
Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia.
Beta-thalassemia is a genetic, red blood cell disorder affecting the...
9th December, 2006
ScientificWorldJournal. 2006 Oct 9;6:1278-97.
DOI Direct Link
SCID repopulating cells derived from unmobilised adult human peripheral blood.
Severe combined immunodeficient (SCID)-repopulating cells (termed SRC)...
22nd April, 2004
TriStem UK Limited, 571 Finchley Road, Unit 320, London NW3 7BN, UK. Curr Med Res Opin. 2004 Jan;20(1):87-100.
DOI Direct Link
Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood.
Undifferentiated pluripotent stem cells with flexible developmental...
25th March, 2004
TriStem Curr Med Res Opin. 2003;19(5):355-75.
DOI Direct Link
Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database.
Human endogenous retroviruses (HERVs) were first identified almost 20...
29th April, 2000
Department of Biology, Imperial College, Silwood Park, Ascot, Berkshire J Virol. 2000 Apr;74(8):3715-30.

View more TriStem research publications.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 360 times since April 2007, the link to the organisation's website has been followed 116 times

Recent Search Terms used to find this page: Tristem Technologies | Tristem Technologies london | Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood | Retrodifferentiated Stem Cells | TriStem UK Limited | tristem | tristem | 571 Finchley Road Unit 320 London NW3 7BN | Tristem uk | retrodifferentiation technology | .

Search for more companies in London

Search for more companies in London



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TriStem

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.